In line with TGF-β acting as a tumour suppressor during the early stages of cancer development, a meta-analysis of 39 case–control studies indicated that rs1982073 was significantly associated with breast cancer risk in the Asian population [173]. Here, TGFB1 is linked to breast carcinoma.